- Home
- MAS vs PEN Comparison
MAS vs PEN Comparison
Compare MAS & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAS | PEN |
|---|---|---|
| Founded | 1929 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 12.6B |
| IPO Year | 1994 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MAS | PEN |
|---|---|---|
| Price | $69.97 | $319.39 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 16 |
| Target Price | $80.13 | ★ $360.14 |
| AVG Volume (30 Days) | ★ 1.4M | 278.2K |
| Earning Date | 04-22-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.80% | N/A |
| EPS Growth | 2.66 | ★ 1155.56 |
| EPS | 1.05 | ★ 1.70 |
| Revenue | ★ $7,562,000,000.00 | $1,403,665,000.00 |
| Revenue This Year | $2.70 | $14.34 |
| Revenue Next Year | $3.40 | $13.71 |
| P/E Ratio | ★ $64.51 | $187.52 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $58.16 | $221.26 |
| 52 Week High | $83.64 | $362.41 |
Technical Indicators
Market Signals| Indicator | MAS | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 42.94 | 44.07 |
| Support Level | $67.81 | $315.31 |
| Resistance Level | $71.56 | $320.45 |
| Average True Range (ATR) | 1.57 | 1.81 |
| MACD | -0.01 | -0.18 |
| Stochastic Oscillator | 32.48 | 28.62 |
Price Performance
Historical ComparisonAbout MAS Masco Corporation
Masco is a global manufacturer of branded home improvement products, with a focus on plumbing fixtures (70% of revenue) and decorative architectural coatings (30% of revenue). The company primarily serves the repair and remodel market, with products such as faucets, showerheads, and paint sold through retail, wholesale, and e-commerce channels. Its portfolio includes well-known brands such as Delta, Hansgrohe, and Behr.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.